IP Library Granted Patent US 11,752,174
Granted Patent B2
US 11,752,174 · App. 17/120,626 · Granted Sep 12, 2023

Placental tissue grafts and improved methods of preparing and using the same

Inventors: John Daniel (Woodstock, GA); Randall Spencer (Acworth, GA); John Russo (Sarasota, FL); Robert Tofe (Denver, CO)
Assignee: MiMedx Group, Inc.
A61K35/28A61K35/19A61K35/33A61K35/50A61L27/3604A61L27/3683A61L27/3834A61L27/56A61F2210/00A61F2230/00A61L2430/34A61L2430/40Y10T156/10Y10T156/1039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,752,174
App. No.
17/120,626
Granted
Sep 12, 2023
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims (20)

1. A tissue graft comprising a first membrane comprising an amnion and at least one additional membrane laminated to the first membrane, wherein the amnion comprises a basement membrane, a compact layer, and a fibroblast layer, and the at least one additional membrane is adjacent to the fibroblast layer;

wherein each additional membrane consists of amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fascia, or any combination thereof; and

wherein said graft comprises a plurality of holes.

2. The graft of claim 1 , wherein the at least one additional membrane comprises amnion, chorion, or a combination thereof.

3. The graft of claim 1 , wherein said at least one additional membrane comprises at least two amnion membranes.

4. The graft of claim 1 , wherein said at least one additional membrane comprises four amnion membranes.

5. The graft of claim 1 , wherein the at least one additional membrane comprises chorion.

6. The graft of claim 1 , wherein the tissue graft further comprises a second membrane comprising an exposed basement membrane and stromal layer, wherein the stromal layer of the second membrane is laminated to the at least one additional membrane.

7. The graft of claim 1 , wherein at least one of the membranes comprises a naturally occurring growth factor, a platelet concentrate, a bone marrow aspirate, stem cells, or an antibiotic.

8. The graft of claim 1 , wherein the number of membranes laminated to the first membrane is from 1 to 10.

9. The graft of claim 1 , wherein the graft has a thickness from 0.2 mm to 10 mm.

10. The graft of claim 1 , wherein the holes have a diameter from 0.2-2.0 mm.

11. The graft of claim 1 , wherein the holes have a diameter from 0.2-0.5 mm.

12. The graft of claim 1 , wherein the holes are spaced from 1 mm to 5 mm apart.

13. The graft of claim 1 , wherein the holes are spaced from 2 mm to 4 mm apart.

14. A method for treating a wound present on mucosal tissue of a subject comprising applying the tissue graft of claim 1 to the wound.

15. The method of claim 14 , wherein the mucosal tissue is present in the oral cavity, nose, throat, vagina, or rectum of the subject.

16. A method for treating a dental defect in a subject comprising applying the tissue graft of claim 1 to the defect.

17. The method of claim 16 , wherein the dental defect comprises a gingival recession, a root carie, or an exposed root.

18. The method of claim 16 , wherein the graft is applied to directly to the surface of a tooth root.

Assignments (5)
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: DANIEL, JOHN; SPENCER, RANDALL; RUSSO, JOHN
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 055577/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 055577/0545 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 055577/0551 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 055577/0558 →
Continuity (14)
Continuation 15716135 · Sep 26, 2017
Continuation 14804156 · Jul 20, 2015
Continuation 14323964 · Jul 3, 2014
Continuation 14262590 · Apr 25, 2014
Continuation 14171511 · Feb 3, 2014
Continuation 13861305 · Apr 11, 2013
Continuation 13765640 · Feb 12, 2013
Continuation 13569134 · Aug 7, 2012
Continuation 12428908 · Apr 23, 2009
Continuation 12206508 · Sep 8, 2008
Provisional Application 60989299 · Nov 20, 2007
Provisional Application 60986665 · Nov 9, 2007
Provisional Application 60970780 · Sep 7, 2007
Related Publication 20210093672A1 · Apr 1, 2021